Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Rigel Pharma earns $25M AstraZeneca payment tied to potential rheumatoid arthritis treatment
Yahoo/AP
Wed, 09/29/10 - 10:49 am
Tags:
Rigel, AstraZeneca, milestone payments, rheumatoid arthritis, fostamatinib
Study: Give more statins, save more money
Fierce Pharma
Tue, 09/28/10 - 03:26 pm
Tags:
statins, CRP, AstraZeneca, Crestor
The most (and least) efficient Big Pharma companies
Fierce Pharma
Tue, 09/28/10 - 11:54 am
Tags:
Roche, Bristol-Myers Squibb, Eli Lilly, JNJ, GSK, AstraZeneca, Novartis, Pfizer, Abbott Laboratories, Sanofi, Merck, Bayer
AstraZeneca Prostate Cancer Drug Fails
TheStreet.com
Mon, 09/27/10 - 10:40 am
Tags:
prostate cancer, AstraZeneca, zibotentan, Dendreon, Provenge
Prepare for This $12 Billion Whoosh (Lipitor Generic)
Motley Fool
Sat, 09/25/10 - 12:16 pm
Tags:
Pfizer, Lipitor, AstraZeneca, Crestor, Merck, Zocor
Priority Review for AZN Drug
Yahoo/Zacks
Sat, 09/25/10 - 12:14 pm
Tags:
AstraZeneca, vandetanib, thyroid cancer
AstraZeneca, Bristol Myers Move Forward With Diabetes Drug
Minyanville
Sat, 09/25/10 - 12:11 pm
Tags:
AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
AstraZeneca Wins EU Approval for Blood Thinner to Rival World's No. 2 Drug
Bloomberg
Fri, 09/24/10 - 10:03 am
Tags:
AstraZeneca, blood thinners, Europe, Plavix, Brilique, Brilinta
AZ/Rigel RA drug hits PhIIb paydirt
Fierce Biotech
Thu, 09/23/10 - 09:45 am
Tags:
Rigel, rheumatoid arthritis, AstraZeneca
Dendreon: Assessing New Threat to Provenge
TheStreet.com
Wed, 09/22/10 - 11:40 am
Tags:
Provenge, Dendreon, vaccines, prostate cancer, AstraZeneca, zibotentan
Dapagliflozin: Potential Blockbuster, No Me-Too About It
Motley Fool
Tue, 09/21/10 - 11:13 am
Tags:
diabetes, Bristol-Myers Squibb, Dapagliflozin, AstraZeneca
AstraZeneca Urges Increase in FDA Funding
Yahoo
Tue, 09/21/10 - 09:14 am
Tags:
FDA, AstraZeneca
Bristol-Myers and AstraZeneca say dapagliflozin helped diabetes patients reduce blood sugar
Yahoo/AP
Mon, 09/20/10 - 11:35 am
Tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, diabetes
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Seeking Alpha
Mon, 09/20/10 - 10:58 am
Tags:
blood thinners, AstraZeneca, Bristol-Myers Squibb, Bayer, Eisai, Pfizer, Sanofi, Brilinta, Portola Pharmaceuticals, Boehringer Ingelheim
FDA Pushes Out Brilinta Action Date
Yahoo/Zacks
Sat, 09/18/10 - 11:01 am
Tags:
AstraZeneca, Brilinta, acute coronary syndrome, Plavix, Bristol-Myers Squibb
AstraZeneca Pensions: CEO, Yes - Workers, No
Seeking Alpha
Thu, 09/16/10 - 12:16 pm
Tags:
AstraZeneca, pensions, executive pay
The Next Big Rare Disease Drug?
Forbes
Wed, 09/15/10 - 09:46 pm
Tags:
Incyte, Novartis, Janus kinase, AstraZeneca, Eli Lilly, Sanofi
FDA extends time for AstraZeneca's ticagrelor NDA
Marketwatch
Wed, 09/15/10 - 08:04 am
Tags:
AstraZeneca, FDA, Ticagrelor, Brilinta, anti-clotting
Cholesterol-Lowering Drug Crestor Cuts Risk of Catching Pneumonia in Study
Bloomberg
Mon, 09/13/10 - 12:18 pm
Tags:
statins, AstraZeneca, Crestor, pneumonia
FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Yahoo/PR NewsWire
Sat, 09/11/10 - 11:28 am
Tags:
Faslodex, .breast cancer, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.